Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Dieguez-Acuña F, Kodama S, Okubo Y, Paz AC, Gygi SP, Faustman DL. Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen. Int J Biochem Cell Biol. 2010 Oct; 42(10):1651-60.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.